alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the quarterly report of Hypertension Diagnostics, Inc. (the “Company”) on Form 10-Q for the quarter ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kenneth W. Brimmer, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the accompanying Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  /s/ Kenneth W. Brimmer Chief Executive Officer and Chief Financial Officer   Date:  February 14, 2012                                20
## Summary Measures and Graphs

- Individual Provisions
- Cost-of-Living Adjustment

### **Description of Proposed Provision:						A8: Starting December 2024, for OASI beneficiaries only (DI beneficiaries would only be affected when their benefit converts to OASI at NRA), the annual COLA would be based on the chain-weighted version of the CPI-U.**

|  |  |
|--|--|
CONSENT OF INDEPENDENT ACCOUNTS

We consent to the incorporation by reference in the registration statement
report of SLM International, Inc. on Form S-8 (File No. 33-53996) of our report
which includes an explanatory paragraph regarding the Company's accounting for
the Plan of Reorganisation, dated April 14, 1997, on St-Lawrence Manufacturing
Canada Inc. (formerly Buddy L Canada Inc.), on Sport Maska Inc., on #1 Apparel
Canada Inc., our reports which include an explanatory paragraph regarding
uncertainties as to the ability of the company to continue as a going concern
dated April 25, 1996 on St-Lawrence Manufacturing Canada Inc., on Sport Maska
Inc., on #1 Apparel Canada Inc. and dated April 14, 1995 on Buddy L Canada Inc.,
on Sport Maska Inc., on #1 Apparel Canada Inc.

Chartered Accountants

/s/ RAYMOND, CHABOT, MARTIN, PARE
Montreal, Canada
April 14, 1997
II 

117TH CONGRESS 

2D SESSION S. 3485 

To ensure that the right to vote shall not be impaired due to vaccination 

status. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 12 (legislative day, JANUARY 10), 2022 

Mr. CRUZ introduced the following bill; which was read twice and referred to 

the Committee on Rules and Administration 

A BILL 

To ensure that the right to vote shall not be impaired due 

to vaccination status. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Securing Enfranchise5 ment and the Rights of Voters regardless of Inoculation 

6 Status Act’’ or the ‘‘SERVIS Act’’. 

7 SEC. 2. RIGHT TO VOTE SHALL NOT BE IMPAIRED. 

8 (a) IN GENERAL.—It shall be unlawful for any State 

9 or political subdivision, as such term is used in the Voting 

10 Rights Act of 1965 (52 U.S.C. 10301 et seq.), to require 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•S 3485 IS

1 or impose a requirement that a voter or voters must 

2 present a vaccine passport or otherwise present informa3 tion regarding their vaccination status in order to exercise 

4 the right to vote, including to vote in person, in any elec5 tion involving any candidate for Federal office. 

6 (b) MASKING REQUIREMENT.—A State or political 

7 subdivision may require that a voter wear a mask in order 

8 to enter a polling location only if— 

9 (1) the State or political subdivision makes 

10 readily available and at no cost to the voter or any 

11 individual who accompanies the voter a mask suffi12 cient to comply with any applicable masking require13 ment; and 

14 (2) the State or political subdivision provides 

15 reasonable accommodation from such requirement 

16 for individuals with a disability as recognized under 

17 the Americans with Disabilities Act of 1990 (42 

18 U.S.C. 12101 et seq.). 

19 (c) DEFINITION.—For purposes of this section, the 

20 term ‘‘vaccination status’’ means— 

21 (1) an individual’s status based on the vol22 untary election to receive or not to receive a 

23 COVID–19 vaccine; and 

24 (2) regardless of whether someone has or has 

25 not been vaccinated against COVID–19, an individVerDate Sep 11 2014 00:33 Jan 13, 2022 Jkt 029200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S3485.IS S3485

pbinns on DSKJLVW7X2PROD with BILLS
3 

•S 3485 IS

1 ual’s status with respect to having or producing 

2 proof of such vaccination in the form of a vaccine 

3 passport or other medical records that would dem4 onstrate whether an individual has been vaccinated 

5 against COVID–19. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS
#### Catharine Zapp v. Charles J. Miller.

— Appeal stricken from calendar, and case directed to be made and settled. Mem. by

Daniels, J.
Exhibit 4.1


 





Axio Financial LLC


60 East 42nd Street, 26th Floor

New York, New York 10165


 


 


 
December 13, 2022


  


 


Preservation 100 Fund, m+ funds Trust, Series 7-10


 


c/o The Bank of New York Mellon, as Trustee

240 Greenwich Street, 22W Floor


New York, New York 10286 


 


		Re:	m+ funds Trust, Series 7-10 (the “Trust”)



 


 


Ladies and Gentlemen:


 




We have examined Amendment No 1 to the Registration
Statement (File No. 333-268436) for the above captioned Trust. We hereby consent to the use in the Registration Statement of the references
to Axio Financial LLC as depositor performing evaluation services for the Trust. 



 


You are hereby authorized to file a copy of this
letter with the Securities and Exchange Commission.


 


 


 


	 	Very truly yours,	 
	 	 	 
	 	Axio
Financial LLC 
	 
	 	 	 
	 	By:	/s/ Stephen Clancy	 
	 	 	Name: Stephen Clancy	 
	 	 	Title:  Senior Vice President
Exhibit 32.1



CERTIFICATION
PURSUANT TO

18 U.S.C.
SECTION 1350,

AS ADOPTED
PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY
ACT OF 2002



In connection
with this Quarterly Report of Fresh Promise Foods, Inc. (the “Company”), on Form 10-Q for the period ended March 31,
2015, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Kevin P. Quirk, Principal Executive Officer
of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley
Act of 2002, that:



| | (1) | Such Quarterly Report
    on Form 10-Q for the period ended March 31, 2015, fully complies with the requirements of section 13(a) or 15(d) of the Securities
    Exchange Act of 1934; and                               
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                                                                                          
| | (2) | The information
    contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2015, fairly presents, in all material respects,
    the financial condition and results of operations of the Company.





|Dated:
    April 27, 2018 | FRESH PROMISE FOODS, INC.
|------------------------- | -------------------------
|                          | (Registrant)             
|                          |                          
|                          | /s/ Joe E. Poe,
    Jr.  
|                          | Joe E. Poe, Jr.          
|                          | Chief Executive Officer
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3669 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
                                S. 3669

To amend the Internal Revenue Code of 1986 to modify rules relating to 
                          like kind exchanges.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 16, 2022

Mr. Lee (for himself, Mr. Braun, Mr. Cruz, and Mr. Marshall) introduced 
the following bill; which was read twice and referred to the Committee 
                               on Finance

_______________________________________________________________________

                                 A BILL

 
To amend the Internal Revenue Code of 1986 to modify rules relating to 
                          like kind exchanges.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``1031 Exchange Improvement Act''.

SEC. 2. PROPERTY IDENTIFICATION REQUIREMENT.

    (a) In General.--Subparagraph (A) of section 1031(a)(3) of the 
Internal Revenue Code of 1986 is amended by striking ``the day which'' 
and all that follows through the comma and inserting ``the date such 
property is received,''.
    (b) Effective Date.--The amendment made by this section shall apply 
to exchanges completed after the date of the enactment of this Act.
                                 <all>
```
Long-range 

actuarial 

balance

Annual 

balance in 

75th year

Long-range 

actuarial 

balance

Annual 

balance in 

75th year

Long-range 

actuarial 

balance

Annual 

balance in 

75th year

-3.61 -4.35 0.14 0.10 4% 2%

Estimates based on the intermediate assumptions of the 2023 Trustees Report Office of the Chief Actuary

Social Security Administration

September 15, 2023

Summary Measures and Graphs

Category of Change: Payroll Taxes (including maximum taxable)

Current law

[percent of payroll]

Change from current law

[percent of payroll] Shortfall eliminated

Proposed Provision: E3.10. Beginning in 2031, apply 2 percent payroll tax rate on earnings over the wageindexed equivalent of $300,000 in 2017 (about $522,300 in 2031), with the threshold wage-indexed after 

2031. Provide proportional benefit credit for additional earnings taxed, based on the payroll tax rate applied 

to the additional earnings divided by the full 12.4 percent payroll tax rate.

6.0

8.0

10.0

12.0

14.0

16.0

18.0

20.0

2023 2030 2040 2050 2060 2070 2080 2090

Percent

Year

OASDI Cost Rates and Income Rates

(as a percentage of taxable payroll)

Income rates under current law

Income rates with this provision

Cost rates under current law

Cost rates with this provision

0

100

200

300

400

500

600

2023 2030 2040 2050 2060 2070 2080 2090

Percent

Year

OASDI Trust Fund Ratio

(assets as a percentage of annual expenditures)

Current law With this provision
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 3601 Introduced in Senate (IS)]

<DOC>

117th CONGRESS
  2d Session
                                S. 3601

To require the Administrator of the Federal Emergency Management Agency 
 to include breast pumps and other lactation supplies and equipment in 
                disaster relief and emergency response.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

             February 8 (legislative day, February 3), 2022

  Ms. Duckworth (for herself and Mr. Tillis) introduced the following 
 bill; which was read twice and referred to the Committee on Homeland 
                   Security and Governmental Affairs

_______________________________________________________________________

                                 A BILL

 
To require the Administrator of the Federal Emergency Management Agency 
 to include breast pumps and other lactation supplies and equipment in 
                disaster relief and emergency response.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Delivering Essentials to Mothers 
Amid Natural Disasters Act of 2022'' or the ``DEMAND Act of 2022''.

SEC. 2. LACTATION SUPPORT PROVIDER DEFINED.

    In this Act, the term ``lactation support provider''--
            (1) means an individual who is a breastfeeding and 
        lactation educator or counselor, without regard to the type of 
        license or certification the individual holds, if any; and
            (2) includes--
                    (A) a lactation consultant;
                    (B) a breastfeeding counselor;
                    (C) a breastfeeding peer counselor; and
                    (D) a lactation educator.

SEC. 3. BREASTFEEDING SUPPLIES AND SUPPORT SERVICES.

    Not later than 90 days after the date of enactment of this Act, the 
Administrator of the Federal Emergency Management Agency, in 
consultation with the head of the Federal Interagency Breastfeeding 
Workgroup, shall designate the following items as items for which 
individuals and households may receive financial assistance under 
section 408(e) of the Robert T. Stafford Disaster Relief and Emergency 
Assistance Act (42 U.S.C. 5174(e)):
            (1) Breast pumps.
            (2) Other lactation supplies appropriate for use in an 
        emergency setting.
            (3) Other equipment necessary to support the safe use of 
        breast pumps.
            (4) Services of lactation support providers.
                                 <all>
```
#### ATWATER v. HUGHES and CROTTS.

(Filed 9 November, 1927.)

Civil actioN, before *Midyette, J.,*at March Term, 1927, of Dubham.

Plaintiff brought suit against tbe defendants on a promissory note. Tbe defendants alleged tbat tbe note as drawn was payable one year after date, whereas there was an agreement between tbe parties tbat it should be payable three years after date, and asked for reformation of tbe note upon tbe ground of fraud, and as a cause of action against tbe plaintiff, set up a counterclaim for damages arising from misrepresentation in a sale of timber made by tbe plaintiff to tbe defendants, said note being part of tbe purchase price.

Issues of fraud and damage were submitted to tbe jury and answered against tbe defendants and in favor of tbe plaintiff for tbe face amount of said note witb interest thereon.

From judgment upon tbe verdict tbe defendants appealed.

*McLendon & Hedrick for plaintiff.*

*Mel J. Thompson for defendants.*

Per Cubiam.

Tbis record presents solely and exclusively a question of fact. Tbe cause was submitted to tbe jury upon a charge totally free from error. A consideration of tbe entire record unerringly leads to tbe conclusion tbat tbe rights of tbe parties have been determined in accordance witb law.

No error.
**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

          We haveissued our report dated July 26, 2006, accompanying the consolidated financialstatements on Form 10-K for the years ended April 30, 2006 and 2005. We herebyconsent to the incorporation by reference of said report in the RegistrationStatements of Unify Corporation on Forms S-2 (File No. 333-117628, effectiveApril 29, 2005 and File No. 333-124488, effective July 29, 2005) and on FormsS-8 (File No. 333-13203, effective October 1, 1996, File No. 333-61705,effective August 18, 1998, File No. 333-92973, effective December 17, 1999, FileNo. 333-71814, effective October 18, 2001, File No. 333-98633,  effective August 23, 2002, and File No. 333-120750, effective November24, 2004).

| /s/ GRANT THORNTON LLP  |   |
|-------------------------|--------|
|                         |   |
| Reno, Nevada            |   |
|                    |   |
| July 26, 2006 |   |
Exhibit 21.1

PERFUMANIA HOLDINGS, INC.

SUBSIDIARIES OF THE REGISTRANT



|                                           |  |                       
|------------------------------------------ |  | ----------------------
|NAME OF SUBSIDIARY                         |  | STATE OF INCORPORATION
|Perfumania, Inc.                           |  | Florida               
|                                           | 
|Magnifique Parfumes and Cosmetics, Inc.    |  | Florida               
|                                           | 
|Perfumania Puerto Rico, Inc.               |  | Puerto Rico           
|                                           | 
|Ten Kesef II, Inc.                         |  | Florida               
|                                           | 
|perfumania.com, inc.                       |  | Florida               
|                                           | 
|Perfumania International Franchising, Inc. |  | Florida               
|                                           | 
|Quality King Fragrance, Inc.               |  | New York              
|                                           | 
|Five Star Fragrance Company, Inc.          |  | New York              
|                                           | 
|Scents of Worth                            |  | Florida               
|                                           | 
|Model Reorg Acquisition, LLC               |  | Delaware
*

Honorable Wilbur D. Owens, Jr., Senior U.S. District Judge

for the Middle District of Georgia, sitting by designation. 

United States Court of Appeals,

Eleventh Circuit.

No. 94-8730.

UNITED STATES of America, Plaintiff-Appellee,

v.

Donald DEROSE, Roberta Ould, Defendants-Appellants.

March 15, 1996.

Appeals from the United States District Court for the Northern

District of Georgia (No. 1:93-CR-236), Jack T. Camp, Judge.

Prior report: 74 F.3d 1177.

Before HATCHETT and CARNES, Circuit Judges, and OWENS*

, Senior

District Judge.

BY THE COURT:

Appellees' motion to modify published opinion is GRANTED. The

published opinion shall be modified as follows:

(1) By addition the word "initially" after the word "attorney"

and before the word "assigned" in the fourth sentence of the second

paragraph of the "Procedural History" section of the opinion. The

corrected sentence should read "The magistrate judge noted that the

one-year delay between the probable cause hearing and the dismissal

of the complaint was attributable to the "gross negligence' of the

assistant United States Attorney initially assigned to the case."

(2) By adding a footnote in the opinion following the

above-stated corrected sentence, which should read, "Neither of the

two attorneys listed in this opinion as counsel for the United

States of America on appeal was the Assistant United States
Attorney to whom the magistrate judge was referring."
[Federal Register Volume 60, Number 27 (Thursday, February 9, 1995)]
[Notices]
[Page 7774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-3300]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 91F-0324]


Goodyear Tire & Rubber Co.; Filing of Food Additive Petition; 
Amendment; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of January 26, 1995 (60 FR 5184). 
The document amended the filing notice for a food additive petition 
filed by the Goodyear Tire & Rubber Co. to indicate that the petitioned 
additive, alkylthiophenolics, acid-catalyzed condensation reaction 
products of p-nonylphenol, formaldehyde, and 1-dodecanethiol, is also 
intended for use in pressure-sensitive adhesives. The document was 
published with some editorial errors. This document corrects those 
errors.

FOR FURTHER INFORMATION CONTACT: Andrew Zajac, Center for Food Safety 
and Applied Nutrition (HFS-216), Food and Drug Administration, 200 C 
St. SW., Washington, DC 20204, 202-418-3095.
    In FR Doc. 95-2007, appearing on page 5184 in the Federal Register 
of Thursday, January 26, 1995, the following corrections are made:
    On page 5184, in the second column, in the first full paragraph, in 
line 6, and in the third column, in line 13, the word 
``alkylthiophendics'' is corrected to read ``alkylthiophenolics''.

    Dated: February 3, 1995.
Alan M. Rulis,
Acting Director, Office of Premarket Approval, Center for Food Safety 
and Applied Nutrition.
[FR Doc. 95-3300 Filed 2-8-95; 8:45 am]
BILLING CODE 4160-01-F
II 

117TH CONGRESS 

1ST SESSION S. 3339 

To limit cost sharing for prescription drugs, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

DECEMBER 8, 2021 

Mr. WARNOCK (for himself, Ms. KLOBUCHAR, Mr. MENENDEZ, Ms. BALDWIN, 

Mr. REED, Mrs. MURRAY, Ms. SMITH, Mr. HEINRICH, Mr. 

BLUMENTHAL, Ms. HIRONO, and Mr. VAN HOLLEN) introduced the following bill; which was read twice and referred to the Committee on 

Health, Education, Labor, and Pensions 

A BILL 

To limit cost sharing for prescription drugs, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Capping Prescription 

5 Costs Act of 2021’’. 

6 SEC. 2. CAP ON PRESCRIPTION DRUG COST-SHARING. 

7 (a) QUALIFIED HEALTH PLANS.—Section 1302(c) of 

8 the Patient Protection and Affordable Care Act (42 

9 U.S.C. 18022(c)) is amended— 


kjohnson on DSK79L0C42PROD with BILLS
2 

•S 3339 IS

1 (1) in paragraph (3)(A)(i), by inserting ‘‘, in2 cluding cost-sharing with respect to prescription 

3 drugs covered by the plan’’ after ‘‘charges’’; and 

4 (2) by adding at the end the following: 

5 ‘‘(5) PRESCRIPTION DRUG COST-SHARING.— 

6 ‘‘(A) 2023.—For plan years beginning in 

7 2023, the cost-sharing incurred under a health 

8 plan with respect to prescription drugs covered 

9 by the plan shall not exceed $250 per month for 

10 each enrolled individual, or $500 for each fam11 ily. 

12 ‘‘(B) 2024 AND LATER.— 

13 ‘‘(i) IN GENERAL.—In the case of any 

14 plan year beginning in a calendar year 

15 after 2023, the limitation under this para16 graph shall be equal to the applicable dol17 lar amount under subparagraph (A) for 

18 plan years beginning in 2023, increased by 

19 an amount equal to the product of that 

20 amount and the medical care component of 

21 the consumer price index for all urban con22 sumers (as published by the Bureau of 

23 Labor Statistics) for that year. 

24 ‘‘(ii) ADJUSTMENT TO AMOUNT.—If 

25 the amount of any increase under clause 


kjohnson on DSK79L0C42PROD with BILLS
3 

•S 3339 IS

1 (i) is not a multiple of $5, such increase 

2 shall be rounded to the next lowest mul3 tiple of $5.’’. 

4 (b) GROUP HEALTH PLANS.—Section 2707(b) of the 

5 Public Health Service Act (42 U.S.C. 300gg–6(b)) is 

6 amended— 

7 (1) by striking ‘‘annual’’; and 

8 (2) by striking ‘‘paragraph (1) of section 

9 1302(c)’’ and inserting ‘‘paragraphs (1) and (5) of 

10 section 1302(c) of the Patient Protection and Af11 fordable Care Act’’. 

12 (c) EFFECTIVE DATE.—The amendments made by 

13 subsections (a) and (b) shall take effect with respect to 

14 plans beginning after December 31, 2022. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS